基因转移技术的全球市场

2030年，全球基因转移技术市场规模将达到49亿美元

全球基因转移技术市场规模预计在2024年为30亿美元，预计到2030年将达到49亿美元，2024年至2030年的复合年增长率为8.7%。生物模式是本报告分析的细分市场之一，预计其复合年增长率为10.3%，到分析期结束时规模将达到32亿美元。化学模式细分市场在分析期间的复合年增长率预计为5.8%。

美国市场规模估计为 8.055 亿美元，中国市场预计复合年增长率为 13.9%

美国基因转移技术市场规模预计2024年达到8.055亿美元。作为世界第二大经济体，中国预计到2030年市场规模将达到11亿美元，在2024-2030年的分析期间内，复合年增长率为13.9%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个市场的复合年增长率分别为4.3%和8.4%。在欧洲，预计德国市场的复合年增长率为5.8%。

全球基因转移技术市场—主要趋势与驱动因素摘要

为什么基因转移技术是现代治疗和基因组医学的核心？

基因递送技术作为基因治疗、基因组编辑和个人化医疗的基本推动者，正在彻底改变生物医学研究和临床治疗的模式。这些技术有助于将遗传物质（如 DNA、RNA 或 CRISPR-Cas 系统）安全有效地引入目标细胞，这一过程对于纠正基因缺陷、调节基因表现或创建疾病模型至关重要。随着人们对遗传疾病、癌症和病毒感染的兴趣日益浓厚，对可靠的基因传递平台的需求也激增。与传统药物不同，基于基因的干预措施需要精准、有针对性的递送才能有效且安全，因此增加了病毒载体（例如腺结合病毒、慢病毒、逆转录病毒）和非病毒方法（例如脂质奈米颗粒、电穿孔和基于聚合物的系统）的重要性。依赖脂质递送的 COVID-19 mRNA 疫苗最近取得成功，进一步检验了基因递送工具的商业性和治疗可行性，并引发了前所未有的研究资金和跨行业合作。

有哪些新技术可以提高基因转殖的安全性、精确度和扩充性？

技术创新大大提高了基因传递系统的能力，解决了过去的局限性，例如免疫抗原性、转染效率和组织特异性。在病毒载体中，新一代衣壳工程腺结合病毒(AAV) 具有更好的趋向性并降低了免疫反应，使全身应用对于血友病、视网膜营养不良和脊髓性肌肉萎缩等疾病更加安全。慢病毒载体以其整合到宿主基因组中而闻名，正在针对干细胞和 CAR-T 细胞疗法进行优化。在非病毒方面，脂质奈米颗粒 (LNP) 已迅速成为前沿，提供高效率、模组化设计和低毒性，尤其是在基于 mRNA 的疗法中。电穿孔和基于微流体的系统在体外应用中越来越受欢迎，尤其是在自体细胞疗法中。此外，目前正在研究能够响应pH值、酶或外部触发因素（例如光和超音波）的智慧递送平台，以改善位点特异性基因释放。这些创新不仅可以改善治疗效果，还能支援符合GMP标准的大规模生产，这对于临床和商业性部署至关重要。

临床流程、监管趋势和产业投资将发挥什么作用？

肿瘤学、神经病学和罕见疾病领域基因疗法临床管线的快速扩张是基因传递技术市场的关键催化剂。随着美国FDA 和 EMA 等监管机构加快审查程序以获得突破性疗法认定，数十种基于基因的治疗方法正处于临床开发的后期阶段。这种监管势头鼓励新兴企业、生技公司和大型製药公司加强对确保安全性、可重复性和长期疗效的递送平台的投资。递送技术开发商和治疗公司之间的合併、许可协议和研发合作激增表明，递送系统正被视为战略资产，而不是技术副业。此外，监管指导越来越重视载体表征、生物分布和免疫分析。同时，包括国家基因组任务和特定疾病基金会在内的公共和私人资助计划正在支持以递送为重点的研究，以解决服务不足的疾病和人群，进一步扩大全球市场机会。

推动基因转殖技术全球扩张的关键成长要素有哪些？

全球基因递送技术市场的成长受到临床创新、治疗需求和生物技术进步等若干相互关联的因素所驱动。最重要的是，基因治疗临床试验和核准的数量正在增加，这实质上需要针对特定疾病目标和患者群体量身定制的强大且扩充性的递送机制。其次，基因治疗适应症的范围不断扩大，从单病性疾病到复杂的癌症和感染疾病，需要开发多样化且适应性强的递送平台。第三，合成生物学和基因组工程的进步扩大了对精准递送系统的需求，这种系统可以容纳更大的有效载荷、多重基因编辑和严格控制的表现图谱。第四，政府和私部门对基因医学的投资不断增加，正在加速这些平台的开发和商业化。最后，基于 mRNA 的疗法和疫苗的成功证明了非病毒递送系统的市场潜力，刺激了奈米粒子工程、聚合物科学和共轭化学的进一步创新。总的来说，这些因素支持基因传递技术作为下一代医学的基础支柱在全球强劲扩张。

部分

模式（生物模式、化学模式、物理模式）、方法（体外法、体内法、离体法）、应用（基因治疗应用、细胞治疗应用、疫苗应用、研究应用）

受访公司范例（总合34家）

• Alnylam Pharmaceuticals Inc.
• Amgen Inc.
• American Gene Technologies
• AskBio（subsidiary of Bayer AG）
• Astellas Gene Therapies
• Beam Therapeutics Inc.
• Becton, Dickinson and Company
• Bio-Rad Laboratories, Inc.
• BioNTech SE
• Bluebird Bio Inc.
• Catalent, Inc.
• CRISPR Therapeutics AG
• Editas Medicine Inc.
• ElevateBio
• F. Hoffmann-La Roche AG
• Genentech, Inc.
• GenScript ProBio
• Horizon Discovery Ltd.
• Intellia Therapeutics Inc.
• Johnson & Johnson

人工智慧集成

我们正在利用可操作的专家内容和人工智慧工具来改变市场和竞争情报。

Global 特定产业SLM 的典型规范，而是建立了一个从全球专家收集的内容库，其中包括视讯录影、部落格、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地、进出口状况（成品和原始OEM）预测其竞争态势的变化。这种复杂且多面向的市场动态预计将以多种方式影响竞争对手，包括销货成本成本 (COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

• 市场概览
• 主要企业
• 市场趋势和驱动因素
• 全球市场展望

第三章市场分析

• 美国
• 加拿大
• 日本
• 中国
• 欧洲
• 法国
• 德国
• 义大利
• 英国
• 西班牙
• 俄罗斯
• 其他欧洲国家
• 亚太地区
• 澳洲
• 印度
• 韩国
• 其他亚太地区
• 拉丁美洲
• 阿根廷
• 巴西
• 墨西哥
• 其他拉丁美洲
• 中东
• 伊朗
• 以色列
• 沙乌地阿拉伯
• 阿拉伯聯合大公国
• 其他中东地区
• 非洲

第四章 竞赛

Global Gene Delivery Technologies Market to Reach US$4.9 Billion by 2030

The global market for Gene Delivery Technologies estimated at US$3.0 Billion in the year 2024, is expected to reach US$4.9 Billion by 2030, growing at a CAGR of 8.7% over the analysis period 2024-2030. Biological Mode, one of the segments analyzed in the report, is expected to record a 10.3% CAGR and reach US$3.2 Billion by the end of the analysis period. Growth in the Chemical Mode segment is estimated at 5.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$805.5 Million While China is Forecast to Grow at 13.9% CAGR

The Gene Delivery Technologies market in the U.S. is estimated at US$805.5 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.1 Billion by the year 2030 trailing a CAGR of 13.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.3% and 8.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.8% CAGR.

Global "Gene Delivery Technologies" Market - Key Trends & Drivers Summarized

Why Are Gene Delivery Technologies at the Core of Modern Therapeutics and Genomic Medicine?

Gene delivery technologies are revolutionizing the landscape of biomedical research and clinical treatment, serving as the fundamental enablers for gene therapy, genome editing, and personalized medicine. These technologies facilitate the safe and efficient introduction of genetic material-DNA, RNA, or CRISPR-Cas systems-into target cells, a process essential for correcting genetic defects, modulating gene expression, or creating disease models. With the surge in interest surrounding genetic diseases, cancers, and viral infections, the demand for reliable gene delivery platforms has skyrocketed. Unlike traditional pharmaceuticals, gene-based interventions require precise and targeted delivery to be effective and safe, thus elevating the importance of both viral vectors (like adeno-associated virus, lentivirus, and retrovirus) and non-viral methods (such as lipid nanoparticles, electroporation, and polymer-based systems). The recent success of mRNA vaccines for COVID-19, which relied on lipid-based delivery, has further validated the commercial and therapeutic viability of gene delivery tools, sparking unprecedented research funding and cross-industry collaborations.

How Are Emerging Technologies Enhancing Safety, Precision, and Scalability in Gene Delivery?

Technological innovation is dramatically advancing the capabilities of gene delivery systems, addressing past limitations in immunogenicity, transfection efficiency, and tissue specificity. In viral vectors, new-generation adeno-associated viruses (AAVs) with engineered capsids are offering improved tropism and reduced immune responses, making them safer for systemic applications in diseases like hemophilia, retinal dystrophies, and spinal muscular atrophy. Lentiviral vectors, known for their integration into host genomes, are being optimized for stem cell and CAR-T cell therapies. On the non-viral front, lipid nanoparticles (LNPs) have surged to the forefront, especially in mRNA-based therapies, offering high efficiency, modular design, and low toxicity. Electroporation and microfluidic-based systems are gaining traction for ex vivo applications, particularly in autologous cell therapies. Additionally, smart delivery platforms responsive to pH, enzymes, or external triggers (e.g., light or ultrasound) are being explored to improve site-specific gene release. These innovations not only enhance therapeutic outcomes but also support large-scale, GMP-compliant manufacturing-critical for clinical and commercial deployment.

What Role Do Clinical Pipelines, Regulatory Trends, and Industry Investment Play?

The rapid expansion of gene therapy clinical pipelines across oncology, neurology, and rare diseases is a key catalyst for the gene delivery technologies market. Dozens of gene-based therapies are in advanced stages of clinical development, with regulatory bodies such as the U.S. FDA and EMA accelerating review pathways for breakthrough designations. This regulatory momentum is encouraging startups, biotech firms, and pharma giants alike to intensify investment in delivery platforms that ensure safety, reproducibility, and long-term efficacy. Mergers, licensing deals, and R&D collaborations between delivery tech developers and therapeutic companies have spiked, signaling a growing recognition of delivery systems as strategic assets rather than technical afterthoughts. Additionally, regulatory guidance is now increasingly emphasizing vector characterization, biodistribution, and immune profiling-areas directly tied to delivery mechanism design. Meanwhile, public and private funding initiatives, including national genomics missions and disease-specific foundations, are supporting delivery-focused research to address underserved diseases and populations, further expanding global market opportunities.

What Are the Key Growth Drivers Fueling the Global Expansion of Gene Delivery Technologies?

The growth in the global gene delivery technologies market is driven by several interconnected factors stemming from clinical innovation, therapeutic demand, and biotechnological advancement. Foremost is the increasing number of gene therapy trials and approvals, which inherently require robust and scalable delivery mechanisms tailored to specific disease targets and patient populations. Second, the broadening range of gene therapy indications-from monogenic disorders to complex cancers and infectious diseases-is necessitating the development of diverse and adaptable delivery platforms. Third, advances in synthetic biology and genome engineering are expanding the need for precision delivery systems that can accommodate larger payloads, multiplex gene edits, and tightly regulated expression profiles. Fourth, rising investment from both governments and the private sector in genetic medicine is accelerating platform development and commercialization pathways. Lastly, the success of mRNA-based therapeutics and vaccines has demonstrated the market potential for non-viral delivery systems, spurring further innovation in nanoparticle engineering, polymer science, and conjugation chemistry. These factors collectively underpin the robust global expansion of gene delivery technologies as a foundational pillar of next-generation medicine.

SCOPE OF STUDY:

The report analyzes the Gene Delivery Technologies market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Mode (Biological Mode, Chemical Mode, Physical Mode); Method (Ex Vivo Method, In Vivo Method, In Vitro Method); Application (Gene Therapy Application, Cell Therapy Application, Vaccines Application, Research Application)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

• Alnylam Pharmaceuticals Inc.
• Amgen Inc.
• American Gene Technologies
• AskBio (subsidiary of Bayer AG)
• Astellas Gene Therapies
• Beam Therapeutics Inc.
• Becton, Dickinson and Company
• Bio-Rad Laboratories, Inc.
• BioNTech SE
• Bluebird Bio Inc.
• Catalent, Inc.
• CRISPR Therapeutics AG
• Editas Medicine Inc.
• ElevateBio
• F. Hoffmann-La Roche AG
• Genentech, Inc.
• GenScript ProBio
• Horizon Discovery Ltd.
• Intellia Therapeutics Inc.
• Johnson & Johnson

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • Gene Delivery Technologies - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Advances in Viral and Non-Viral Vectors Drive Innovation in Gene Delivery Platforms
  • Rising R&D Investments in Gene Therapies Strengthen Business Case for Delivery Technologies
  • Emergence of mRNA and CRISPR Modalities Throws the Spotlight on Targeted Gene Delivery Systems
  • Clinical Pipeline Expansion in Rare and Genetic Disorders Accelerates Technology Adoption
  • Growing Cell and Gene Therapy Manufacturing Ecosystem Expands Demand for Scalable Delivery Tools
  • Strategic Collaborations Between Biotech and CDMOs Generate Growth in Gene Delivery Outsourcing
  • Regulatory Support for Novel Therapies Spurs Innovation in Safe and Effective Delivery Mechanisms
  • Increased Interest in Tissue- and Cell-Specific Vectors Propels Customization in Delivery Platforms
  • Technological Integration with Nanocarriers and Lipid Particles Expands Functional Capabilities
  • Use of AI and Predictive Models Enhances Precision in Vector Design and Gene Expression Control
  • Rising Investment in In Vivo Delivery for Oncology Applications Sustains Market Momentum
  • Intellectual Property and Licensing Strategies Create Barriers and Competitive Differentiation
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Gene Delivery Technologies Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Gene Delivery Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Gene Delivery Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 4: World 16-Year Perspective for Gene Delivery Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Biological Mode by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Biological Mode by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 7: World 16-Year Perspective for Biological Mode by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Chemical Mode by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Chemical Mode by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 10: World 16-Year Perspective for Chemical Mode by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Physical Mode by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Physical Mode by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 13: World 16-Year Perspective for Physical Mode by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Research Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Research Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 16: World 16-Year Perspective for Research Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Gene Therapy Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Gene Therapy Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 19: World 16-Year Perspective for Gene Therapy Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Cell Therapy Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Cell Therapy Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 22: World 16-Year Perspective for Cell Therapy Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Vaccines Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Vaccines Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 25: World 16-Year Perspective for Vaccines Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Ex Vivo Method by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Ex Vivo Method by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 28: World 16-Year Perspective for Ex Vivo Method by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for In Vivo Method by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for In Vivo Method by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 31: World 16-Year Perspective for In Vivo Method by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for In Vitro Method by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for In Vitro Method by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 34: World 16-Year Perspective for In Vitro Method by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Gene Delivery Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 35: USA Recent Past, Current & Future Analysis for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 36: USA Historic Review for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 37: USA 16-Year Perspective for Gene Delivery Technologies by Mode - Percentage Breakdown of Value Sales for Biological Mode, Chemical Mode and Physical Mode for the Years 2014, 2025 & 2030
  • TABLE 38: USA Recent Past, Current & Future Analysis for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 39: USA Historic Review for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 40: USA 16-Year Perspective for Gene Delivery Technologies by Application - Percentage Breakdown of Value Sales for Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application for the Years 2014, 2025 & 2030
  • TABLE 41: USA Recent Past, Current & Future Analysis for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 42: USA Historic Review for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 43: USA 16-Year Perspective for Gene Delivery Technologies by Method - Percentage Breakdown of Value Sales for Ex Vivo Method, In Vivo Method and In Vitro Method for the Years 2014, 2025 & 2030
• CANADA
  • TABLE 44: Canada Recent Past, Current & Future Analysis for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 45: Canada Historic Review for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 46: Canada 16-Year Perspective for Gene Delivery Technologies by Mode - Percentage Breakdown of Value Sales for Biological Mode, Chemical Mode and Physical Mode for the Years 2014, 2025 & 2030
  • TABLE 47: Canada Recent Past, Current & Future Analysis for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: Canada Historic Review for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 49: Canada 16-Year Perspective for Gene Delivery Technologies by Application - Percentage Breakdown of Value Sales for Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application for the Years 2014, 2025 & 2030
  • TABLE 50: Canada Recent Past, Current & Future Analysis for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Canada Historic Review for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 52: Canada 16-Year Perspective for Gene Delivery Technologies by Method - Percentage Breakdown of Value Sales for Ex Vivo Method, In Vivo Method and In Vitro Method for the Years 2014, 2025 & 2030
• JAPAN
  • Gene Delivery Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 53: Japan Recent Past, Current & Future Analysis for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Japan Historic Review for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 55: Japan 16-Year Perspective for Gene Delivery Technologies by Mode - Percentage Breakdown of Value Sales for Biological Mode, Chemical Mode and Physical Mode for the Years 2014, 2025 & 2030
  • TABLE 56: Japan Recent Past, Current & Future Analysis for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Japan Historic Review for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 58: Japan 16-Year Perspective for Gene Delivery Technologies by Application - Percentage Breakdown of Value Sales for Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application for the Years 2014, 2025 & 2030
  • TABLE 59: Japan Recent Past, Current & Future Analysis for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Japan Historic Review for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 61: Japan 16-Year Perspective for Gene Delivery Technologies by Method - Percentage Breakdown of Value Sales for Ex Vivo Method, In Vivo Method and In Vitro Method for the Years 2014, 2025 & 2030
• CHINA
  • Gene Delivery Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 62: China Recent Past, Current & Future Analysis for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: China Historic Review for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 64: China 16-Year Perspective for Gene Delivery Technologies by Mode - Percentage Breakdown of Value Sales for Biological Mode, Chemical Mode and Physical Mode for the Years 2014, 2025 & 2030
  • TABLE 65: China Recent Past, Current & Future Analysis for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: China Historic Review for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 67: China 16-Year Perspective for Gene Delivery Technologies by Application - Percentage Breakdown of Value Sales for Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application for the Years 2014, 2025 & 2030
  • TABLE 68: China Recent Past, Current & Future Analysis for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: China Historic Review for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 70: China 16-Year Perspective for Gene Delivery Technologies by Method - Percentage Breakdown of Value Sales for Ex Vivo Method, In Vivo Method and In Vitro Method for the Years 2014, 2025 & 2030
• EUROPE
  • Gene Delivery Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 71: Europe Recent Past, Current & Future Analysis for Gene Delivery Technologies by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 72: Europe Historic Review for Gene Delivery Technologies by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 73: Europe 16-Year Perspective for Gene Delivery Technologies by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
  • TABLE 74: Europe Recent Past, Current & Future Analysis for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Europe Historic Review for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 76: Europe 16-Year Perspective for Gene Delivery Technologies by Mode - Percentage Breakdown of Value Sales for Biological Mode, Chemical Mode and Physical Mode for the Years 2014, 2025 & 2030
  • TABLE 77: Europe Recent Past, Current & Future Analysis for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Europe Historic Review for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 79: Europe 16-Year Perspective for Gene Delivery Technologies by Application - Percentage Breakdown of Value Sales for Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application for the Years 2014, 2025 & 2030
  • TABLE 80: Europe Recent Past, Current & Future Analysis for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Europe Historic Review for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 82: Europe 16-Year Perspective for Gene Delivery Technologies by Method - Percentage Breakdown of Value Sales for Ex Vivo Method, In Vivo Method and In Vitro Method for the Years 2014, 2025 & 2030
• FRANCE
  • Gene Delivery Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 83: France Recent Past, Current & Future Analysis for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: France Historic Review for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 85: France 16-Year Perspective for Gene Delivery Technologies by Mode - Percentage Breakdown of Value Sales for Biological Mode, Chemical Mode and Physical Mode for the Years 2014, 2025 & 2030
  • TABLE 86: France Recent Past, Current & Future Analysis for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: France Historic Review for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 88: France 16-Year Perspective for Gene Delivery Technologies by Application - Percentage Breakdown of Value Sales for Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application for the Years 2014, 2025 & 2030
  • TABLE 89: France Recent Past, Current & Future Analysis for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: France Historic Review for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 91: France 16-Year Perspective for Gene Delivery Technologies by Method - Percentage Breakdown of Value Sales for Ex Vivo Method, In Vivo Method and In Vitro Method for the Years 2014, 2025 & 2030
• GERMANY
  • Gene Delivery Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 92: Germany Recent Past, Current & Future Analysis for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Germany Historic Review for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 94: Germany 16-Year Perspective for Gene Delivery Technologies by Mode - Percentage Breakdown of Value Sales for Biological Mode, Chemical Mode and Physical Mode for the Years 2014, 2025 & 2030
  • TABLE 95: Germany Recent Past, Current & Future Analysis for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Germany Historic Review for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 97: Germany 16-Year Perspective for Gene Delivery Technologies by Application - Percentage Breakdown of Value Sales for Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application for the Years 2014, 2025 & 2030
  • TABLE 98: Germany Recent Past, Current & Future Analysis for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Germany Historic Review for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 100: Germany 16-Year Perspective for Gene Delivery Technologies by Method - Percentage Breakdown of Value Sales for Ex Vivo Method, In Vivo Method and In Vitro Method for the Years 2014, 2025 & 2030
• ITALY
  • TABLE 101: Italy Recent Past, Current & Future Analysis for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Italy Historic Review for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 103: Italy 16-Year Perspective for Gene Delivery Technologies by Mode - Percentage Breakdown of Value Sales for Biological Mode, Chemical Mode and Physical Mode for the Years 2014, 2025 & 2030
  • TABLE 104: Italy Recent Past, Current & Future Analysis for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Italy Historic Review for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 106: Italy 16-Year Perspective for Gene Delivery Technologies by Application - Percentage Breakdown of Value Sales for Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application for the Years 2014, 2025 & 2030
  • TABLE 107: Italy Recent Past, Current & Future Analysis for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Italy Historic Review for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 109: Italy 16-Year Perspective for Gene Delivery Technologies by Method - Percentage Breakdown of Value Sales for Ex Vivo Method, In Vivo Method and In Vitro Method for the Years 2014, 2025 & 2030
• UNITED KINGDOM
  • Gene Delivery Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 110: UK Recent Past, Current & Future Analysis for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: UK Historic Review for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 112: UK 16-Year Perspective for Gene Delivery Technologies by Mode - Percentage Breakdown of Value Sales for Biological Mode, Chemical Mode and Physical Mode for the Years 2014, 2025 & 2030
  • TABLE 113: UK Recent Past, Current & Future Analysis for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: UK Historic Review for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 115: UK 16-Year Perspective for Gene Delivery Technologies by Application - Percentage Breakdown of Value Sales for Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application for the Years 2014, 2025 & 2030
  • TABLE 116: UK Recent Past, Current & Future Analysis for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: UK Historic Review for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 118: UK 16-Year Perspective for Gene Delivery Technologies by Method - Percentage Breakdown of Value Sales for Ex Vivo Method, In Vivo Method and In Vitro Method for the Years 2014, 2025 & 2030
• SPAIN
  • TABLE 119: Spain Recent Past, Current & Future Analysis for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Spain Historic Review for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 121: Spain 16-Year Perspective for Gene Delivery Technologies by Mode - Percentage Breakdown of Value Sales for Biological Mode, Chemical Mode and Physical Mode for the Years 2014, 2025 & 2030
  • TABLE 122: Spain Recent Past, Current & Future Analysis for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Spain Historic Review for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 124: Spain 16-Year Perspective for Gene Delivery Technologies by Application - Percentage Breakdown of Value Sales for Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application for the Years 2014, 2025 & 2030
  • TABLE 125: Spain Recent Past, Current & Future Analysis for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Spain Historic Review for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 127: Spain 16-Year Perspective for Gene Delivery Technologies by Method - Percentage Breakdown of Value Sales for Ex Vivo Method, In Vivo Method and In Vitro Method for the Years 2014, 2025 & 2030
• RUSSIA
  • TABLE 128: Russia Recent Past, Current & Future Analysis for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Russia Historic Review for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 130: Russia 16-Year Perspective for Gene Delivery Technologies by Mode - Percentage Breakdown of Value Sales for Biological Mode, Chemical Mode and Physical Mode for the Years 2014, 2025 & 2030
  • TABLE 131: Russia Recent Past, Current & Future Analysis for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Russia Historic Review for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 133: Russia 16-Year Perspective for Gene Delivery Technologies by Application - Percentage Breakdown of Value Sales for Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application for the Years 2014, 2025 & 2030
  • TABLE 134: Russia Recent Past, Current & Future Analysis for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Russia Historic Review for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 136: Russia 16-Year Perspective for Gene Delivery Technologies by Method - Percentage Breakdown of Value Sales for Ex Vivo Method, In Vivo Method and In Vitro Method for the Years 2014, 2025 & 2030
• REST OF EUROPE
  • TABLE 137: Rest of Europe Recent Past, Current & Future Analysis for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Rest of Europe Historic Review for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 139: Rest of Europe 16-Year Perspective for Gene Delivery Technologies by Mode - Percentage Breakdown of Value Sales for Biological Mode, Chemical Mode and Physical Mode for the Years 2014, 2025 & 2030
  • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Rest of Europe Historic Review for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 142: Rest of Europe 16-Year Perspective for Gene Delivery Technologies by Application - Percentage Breakdown of Value Sales for Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application for the Years 2014, 2025 & 2030
  • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Rest of Europe Historic Review for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 145: Rest of Europe 16-Year Perspective for Gene Delivery Technologies by Method - Percentage Breakdown of Value Sales for Ex Vivo Method, In Vivo Method and In Vitro Method for the Years 2014, 2025 & 2030
• ASIA-PACIFIC
  • Gene Delivery Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Gene Delivery Technologies by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 147: Asia-Pacific Historic Review for Gene Delivery Technologies by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 148: Asia-Pacific 16-Year Perspective for Gene Delivery Technologies by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
  • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Asia-Pacific Historic Review for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 151: Asia-Pacific 16-Year Perspective for Gene Delivery Technologies by Mode - Percentage Breakdown of Value Sales for Biological Mode, Chemical Mode and Physical Mode for the Years 2014, 2025 & 2030
  • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Asia-Pacific Historic Review for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 154: Asia-Pacific 16-Year Perspective for Gene Delivery Technologies by Application - Percentage Breakdown of Value Sales for Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application for the Years 2014, 2025 & 2030
  • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Asia-Pacific Historic Review for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 157: Asia-Pacific 16-Year Perspective for Gene Delivery Technologies by Method - Percentage Breakdown of Value Sales for Ex Vivo Method, In Vivo Method and In Vitro Method for the Years 2014, 2025 & 2030
• AUSTRALIA
  • Gene Delivery Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 158: Australia Recent Past, Current & Future Analysis for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Australia Historic Review for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 160: Australia 16-Year Perspective for Gene Delivery Technologies by Mode - Percentage Breakdown of Value Sales for Biological Mode, Chemical Mode and Physical Mode for the Years 2014, 2025 & 2030
  • TABLE 161: Australia Recent Past, Current & Future Analysis for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Australia Historic Review for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 163: Australia 16-Year Perspective for Gene Delivery Technologies by Application - Percentage Breakdown of Value Sales for Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application for the Years 2014, 2025 & 2030
  • TABLE 164: Australia Recent Past, Current & Future Analysis for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Australia Historic Review for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 166: Australia 16-Year Perspective for Gene Delivery Technologies by Method - Percentage Breakdown of Value Sales for Ex Vivo Method, In Vivo Method and In Vitro Method for the Years 2014, 2025 & 2030
• INDIA
  • Gene Delivery Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 167: India Recent Past, Current & Future Analysis for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: India Historic Review for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 169: India 16-Year Perspective for Gene Delivery Technologies by Mode - Percentage Breakdown of Value Sales for Biological Mode, Chemical Mode and Physical Mode for the Years 2014, 2025 & 2030
  • TABLE 170: India Recent Past, Current & Future Analysis for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: India Historic Review for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 172: India 16-Year Perspective for Gene Delivery Technologies by Application - Percentage Breakdown of Value Sales for Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application for the Years 2014, 2025 & 2030
  • TABLE 173: India Recent Past, Current & Future Analysis for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: India Historic Review for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 175: India 16-Year Perspective for Gene Delivery Technologies by Method - Percentage Breakdown of Value Sales for Ex Vivo Method, In Vivo Method and In Vitro Method for the Years 2014, 2025 & 2030
• SOUTH KOREA
  • TABLE 176: South Korea Recent Past, Current & Future Analysis for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: South Korea Historic Review for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 178: South Korea 16-Year Perspective for Gene Delivery Technologies by Mode - Percentage Breakdown of Value Sales for Biological Mode, Chemical Mode and Physical Mode for the Years 2014, 2025 & 2030
  • TABLE 179: South Korea Recent Past, Current & Future Analysis for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: South Korea Historic Review for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 181: South Korea 16-Year Perspective for Gene Delivery Technologies by Application - Percentage Breakdown of Value Sales for Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application for the Years 2014, 2025 & 2030
  • TABLE 182: South Korea Recent Past, Current & Future Analysis for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: South Korea Historic Review for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 184: South Korea 16-Year Perspective for Gene Delivery Technologies by Method - Percentage Breakdown of Value Sales for Ex Vivo Method, In Vivo Method and In Vitro Method for the Years 2014, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Rest of Asia-Pacific Historic Review for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 187: Rest of Asia-Pacific 16-Year Perspective for Gene Delivery Technologies by Mode - Percentage Breakdown of Value Sales for Biological Mode, Chemical Mode and Physical Mode for the Years 2014, 2025 & 2030
  • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Rest of Asia-Pacific Historic Review for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 190: Rest of Asia-Pacific 16-Year Perspective for Gene Delivery Technologies by Application - Percentage Breakdown of Value Sales for Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application for the Years 2014, 2025 & 2030
  • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Rest of Asia-Pacific Historic Review for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 193: Rest of Asia-Pacific 16-Year Perspective for Gene Delivery Technologies by Method - Percentage Breakdown of Value Sales for Ex Vivo Method, In Vivo Method and In Vitro Method for the Years 2014, 2025 & 2030
• LATIN AMERICA
  • Gene Delivery Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 194: Latin America Recent Past, Current & Future Analysis for Gene Delivery Technologies by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 195: Latin America Historic Review for Gene Delivery Technologies by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 196: Latin America 16-Year Perspective for Gene Delivery Technologies by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
  • TABLE 197: Latin America Recent Past, Current & Future Analysis for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Latin America Historic Review for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 199: Latin America 16-Year Perspective for Gene Delivery Technologies by Mode - Percentage Breakdown of Value Sales for Biological Mode, Chemical Mode and Physical Mode for the Years 2014, 2025 & 2030
  • TABLE 200: Latin America Recent Past, Current & Future Analysis for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Latin America Historic Review for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 202: Latin America 16-Year Perspective for Gene Delivery Technologies by Application - Percentage Breakdown of Value Sales for Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application for the Years 2014, 2025 & 2030
  • TABLE 203: Latin America Recent Past, Current & Future Analysis for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Latin America Historic Review for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 205: Latin America 16-Year Perspective for Gene Delivery Technologies by Method - Percentage Breakdown of Value Sales for Ex Vivo Method, In Vivo Method and In Vitro Method for the Years 2014, 2025 & 2030
• ARGENTINA
  • TABLE 206: Argentina Recent Past, Current & Future Analysis for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Argentina Historic Review for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 208: Argentina 16-Year Perspective for Gene Delivery Technologies by Mode - Percentage Breakdown of Value Sales for Biological Mode, Chemical Mode and Physical Mode for the Years 2014, 2025 & 2030
  • TABLE 209: Argentina Recent Past, Current & Future Analysis for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Argentina Historic Review for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 211: Argentina 16-Year Perspective for Gene Delivery Technologies by Application - Percentage Breakdown of Value Sales for Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application for the Years 2014, 2025 & 2030
  • TABLE 212: Argentina Recent Past, Current & Future Analysis for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Argentina Historic Review for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 214: Argentina 16-Year Perspective for Gene Delivery Technologies by Method - Percentage Breakdown of Value Sales for Ex Vivo Method, In Vivo Method and In Vitro Method for the Years 2014, 2025 & 2030
• BRAZIL
  • TABLE 215: Brazil Recent Past, Current & Future Analysis for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Brazil Historic Review for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 217: Brazil 16-Year Perspective for Gene Delivery Technologies by Mode - Percentage Breakdown of Value Sales for Biological Mode, Chemical Mode and Physical Mode for the Years 2014, 2025 & 2030
  • TABLE 218: Brazil Recent Past, Current & Future Analysis for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Brazil Historic Review for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 220: Brazil 16-Year Perspective for Gene Delivery Technologies by Application - Percentage Breakdown of Value Sales for Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application for the Years 2014, 2025 & 2030
  • TABLE 221: Brazil Recent Past, Current & Future Analysis for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Brazil Historic Review for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 223: Brazil 16-Year Perspective for Gene Delivery Technologies by Method - Percentage Breakdown of Value Sales for Ex Vivo Method, In Vivo Method and In Vitro Method for the Years 2014, 2025 & 2030
• MEXICO
  • TABLE 224: Mexico Recent Past, Current & Future Analysis for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Mexico Historic Review for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 226: Mexico 16-Year Perspective for Gene Delivery Technologies by Mode - Percentage Breakdown of Value Sales for Biological Mode, Chemical Mode and Physical Mode for the Years 2014, 2025 & 2030
  • TABLE 227: Mexico Recent Past, Current & Future Analysis for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Mexico Historic Review for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 229: Mexico 16-Year Perspective for Gene Delivery Technologies by Application - Percentage Breakdown of Value Sales for Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application for the Years 2014, 2025 & 2030
  • TABLE 230: Mexico Recent Past, Current & Future Analysis for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Mexico Historic Review for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 232: Mexico 16-Year Perspective for Gene Delivery Technologies by Method - Percentage Breakdown of Value Sales for Ex Vivo Method, In Vivo Method and In Vitro Method for the Years 2014, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 233: Rest of Latin America Recent Past, Current & Future Analysis for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Rest of Latin America Historic Review for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 235: Rest of Latin America 16-Year Perspective for Gene Delivery Technologies by Mode - Percentage Breakdown of Value Sales for Biological Mode, Chemical Mode and Physical Mode for the Years 2014, 2025 & 2030
  • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Rest of Latin America Historic Review for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 238: Rest of Latin America 16-Year Perspective for Gene Delivery Technologies by Application - Percentage Breakdown of Value Sales for Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application for the Years 2014, 2025 & 2030
  • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Rest of Latin America Historic Review for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 241: Rest of Latin America 16-Year Perspective for Gene Delivery Technologies by Method - Percentage Breakdown of Value Sales for Ex Vivo Method, In Vivo Method and In Vitro Method for the Years 2014, 2025 & 2030
• MIDDLE EAST
  • Gene Delivery Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 242: Middle East Recent Past, Current & Future Analysis for Gene Delivery Technologies by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 243: Middle East Historic Review for Gene Delivery Technologies by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 244: Middle East 16-Year Perspective for Gene Delivery Technologies by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
  • TABLE 245: Middle East Recent Past, Current & Future Analysis for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Middle East Historic Review for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 247: Middle East 16-Year Perspective for Gene Delivery Technologies by Mode - Percentage Breakdown of Value Sales for Biological Mode, Chemical Mode and Physical Mode for the Years 2014, 2025 & 2030
  • TABLE 248: Middle East Recent Past, Current & Future Analysis for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Middle East Historic Review for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 250: Middle East 16-Year Perspective for Gene Delivery Technologies by Application - Percentage Breakdown of Value Sales for Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application for the Years 2014, 2025 & 2030
  • TABLE 251: Middle East Recent Past, Current & Future Analysis for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Middle East Historic Review for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 253: Middle East 16-Year Perspective for Gene Delivery Technologies by Method - Percentage Breakdown of Value Sales for Ex Vivo Method, In Vivo Method and In Vitro Method for the Years 2014, 2025 & 2030
• IRAN
  • TABLE 254: Iran Recent Past, Current & Future Analysis for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Iran Historic Review for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 256: Iran 16-Year Perspective for Gene Delivery Technologies by Mode - Percentage Breakdown of Value Sales for Biological Mode, Chemical Mode and Physical Mode for the Years 2014, 2025 & 2030
  • TABLE 257: Iran Recent Past, Current & Future Analysis for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Iran Historic Review for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 259: Iran 16-Year Perspective for Gene Delivery Technologies by Application - Percentage Breakdown of Value Sales for Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application for the Years 2014, 2025 & 2030
  • TABLE 260: Iran Recent Past, Current & Future Analysis for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Iran Historic Review for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 262: Iran 16-Year Perspective for Gene Delivery Technologies by Method - Percentage Breakdown of Value Sales for Ex Vivo Method, In Vivo Method and In Vitro Method for the Years 2014, 2025 & 2030
• ISRAEL
  • TABLE 263: Israel Recent Past, Current & Future Analysis for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Israel Historic Review for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 265: Israel 16-Year Perspective for Gene Delivery Technologies by Mode - Percentage Breakdown of Value Sales for Biological Mode, Chemical Mode and Physical Mode for the Years 2014, 2025 & 2030
  • TABLE 266: Israel Recent Past, Current & Future Analysis for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Israel Historic Review for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 268: Israel 16-Year Perspective for Gene Delivery Technologies by Application - Percentage Breakdown of Value Sales for Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application for the Years 2014, 2025 & 2030
  • TABLE 269: Israel Recent Past, Current & Future Analysis for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Israel Historic Review for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 271: Israel 16-Year Perspective for Gene Delivery Technologies by Method - Percentage Breakdown of Value Sales for Ex Vivo Method, In Vivo Method and In Vitro Method for the Years 2014, 2025 & 2030
• SAUDI ARABIA
  • TABLE 272: Saudi Arabia Recent Past, Current & Future Analysis for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Saudi Arabia Historic Review for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 274: Saudi Arabia 16-Year Perspective for Gene Delivery Technologies by Mode - Percentage Breakdown of Value Sales for Biological Mode, Chemical Mode and Physical Mode for the Years 2014, 2025 & 2030
  • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Saudi Arabia Historic Review for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 277: Saudi Arabia 16-Year Perspective for Gene Delivery Technologies by Application - Percentage Breakdown of Value Sales for Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application for the Years 2014, 2025 & 2030
  • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Saudi Arabia Historic Review for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 280: Saudi Arabia 16-Year Perspective for Gene Delivery Technologies by Method - Percentage Breakdown of Value Sales for Ex Vivo Method, In Vivo Method and In Vitro Method for the Years 2014, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 281: UAE Recent Past, Current & Future Analysis for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: UAE Historic Review for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 283: UAE 16-Year Perspective for Gene Delivery Technologies by Mode - Percentage Breakdown of Value Sales for Biological Mode, Chemical Mode and Physical Mode for the Years 2014, 2025 & 2030
  • TABLE 284: UAE Recent Past, Current & Future Analysis for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: UAE Historic Review for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 286: UAE 16-Year Perspective for Gene Delivery Technologies by Application - Percentage Breakdown of Value Sales for Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application for the Years 2014, 2025 & 2030
  • TABLE 287: UAE Recent Past, Current & Future Analysis for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: UAE Historic Review for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 289: UAE 16-Year Perspective for Gene Delivery Technologies by Method - Percentage Breakdown of Value Sales for Ex Vivo Method, In Vivo Method and In Vitro Method for the Years 2014, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 290: Rest of Middle East Recent Past, Current & Future Analysis for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Rest of Middle East Historic Review for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 292: Rest of Middle East 16-Year Perspective for Gene Delivery Technologies by Mode - Percentage Breakdown of Value Sales for Biological Mode, Chemical Mode and Physical Mode for the Years 2014, 2025 & 2030
  • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Rest of Middle East Historic Review for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 295: Rest of Middle East 16-Year Perspective for Gene Delivery Technologies by Application - Percentage Breakdown of Value Sales for Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application for the Years 2014, 2025 & 2030
  • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Rest of Middle East Historic Review for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 298: Rest of Middle East 16-Year Perspective for Gene Delivery Technologies by Method - Percentage Breakdown of Value Sales for Ex Vivo Method, In Vivo Method and In Vitro Method for the Years 2014, 2025 & 2030
• AFRICA
  • Gene Delivery Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 299: Africa Recent Past, Current & Future Analysis for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Africa Historic Review for Gene Delivery Technologies by Mode - Biological Mode, Chemical Mode and Physical Mode Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 301: Africa 16-Year Perspective for Gene Delivery Technologies by Mode - Percentage Breakdown of Value Sales for Biological Mode, Chemical Mode and Physical Mode for the Years 2014, 2025 & 2030
  • TABLE 302: Africa Recent Past, Current & Future Analysis for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Africa Historic Review for Gene Delivery Technologies by Application - Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 304: Africa 16-Year Perspective for Gene Delivery Technologies by Application - Percentage Breakdown of Value Sales for Research Application, Gene Therapy Application, Cell Therapy Application and Vaccines Application for the Years 2014, 2025 & 2030
  • TABLE 305: Africa Recent Past, Current & Future Analysis for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Africa Historic Review for Gene Delivery Technologies by Method - Ex Vivo Method, In Vivo Method and In Vitro Method Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 307: Africa 16-Year Perspective for Gene Delivery Technologies by Method - Percentage Breakdown of Value Sales for Ex Vivo Method, In Vivo Method and In Vitro Method for the Years 2014, 2025 & 2030

IV. COMPETITION